NHS England has recently published its clinical policy on puberty suppressing hormones. This sets out that puberty suppressing hormones are not available as a routine commissioning treatment option for treatment of children and young people in England who have gender incongruence/gender dysphoria.
Research commissioned by the GPhC examined how the 2017 standards for the initial education and training of pharmacy technicians (IETPT) have affected professional practice.
The contact centre will be closed on the morning of Thursday 7 March for training purposes and will reopen again at 1pm on the same day. During this time please email any enquiries to info@pharmacyregulation.org.